Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Dr. Lal Pathlabs has informed that the details of proposed schedule of Analyst/Institutional Investor meeting(s) as on 23rd November 2020 with Phaeacian Partners, USA. Dates of the aforesaid meeting/call are subject to change due to exigencies on the part of Investor/Company. No Unpublished Price Sensitive Information will be shared during the meetings. Further details of the same as enclosed.
The above information is a part of company’s filings submitted to BSE.
